María Ángeles
Castro Iglesias
Profesora Titular de Universidad
Hospital del Mar
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital del Mar (7)
2021
-
Resistance-associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure
Journal of Viral Hepatitis, Vol. 28, Núm. 9, pp. 1319-1324
2020
-
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
Antiviral Research, Vol. 174
2015
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
-
Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: The RELAX study
HIV Medicine, Vol. 16, Núm. 10, pp. 628-634
2009
-
Saquinavir exposure in HIV-infected patients with chronic viral hepatitis
Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 5, pp. 992-997
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092
2005
-
Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain
Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70